Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043703
Filing Date
2025-05-15
Accepted
2025-05-15 08:05:55
Documents
91
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241339-10q_synergy.htm   iXBRL 10-Q 696779
2 CERTIFICATION ea024133901ex31-1_synergy.htm EX-31.1 8194
3 CERTIFICATION ea024133901ex31-2_synergy.htm EX-31.2 8247
4 CERTIFICATION ea024133901ex32-1_synergy.htm EX-32.1 3295
5 CERTIFICATION ea024133901ex32-2_synergy.htm EX-32.2 3383
  Complete submission text file 0001213900-25-043703.txt   6649771

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE snyr-20250331.xsd EX-101.SCH 73220
7 XBRL CALCULATION FILE snyr-20250331_cal.xml EX-101.CAL 47144
8 XBRL DEFINITION FILE snyr-20250331_def.xml EX-101.DEF 338703
9 XBRL LABEL FILE snyr-20250331_lab.xml EX-101.LAB 625753
10 XBRL PRESENTATION FILE snyr-20250331_pre.xml EX-101.PRE 361952
93 EXTRACTED XBRL INSTANCE DOCUMENT ea0241339-10q_synergy_htm.xml XML 668767
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42374 | Film No.: 25948829
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)